These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Stem-cell collection before high-dose therapy for multiple myeloma: time has come to raise the standards! Mohty M Leukemia; 2009 Oct; 23(10):1689-90. PubMed ID: 19826430 [No Abstract] [Full Text] [Related]
26. Failure to achieve a threshold dose of CD34+CD110+ progenitor cells in the graft predicts delayed platelet engraftment after autologous stem cell transplantation for multiple myeloma. Wallington-Beddoe CT; Gottlieb DJ; Garvin F; Antonenas V; Sartor MM Biol Blood Marrow Transplant; 2009 Nov; 15(11):1386-93. PubMed ID: 19822297 [TBL] [Abstract][Full Text] [Related]
28. Peripheral blood progenitor cell collection without close monitoring of peripheral blood CD34+ cells: A feasible strategy for multiple myeloma or pre-treated Non-Hodgkin's Lymphoma patients mobilized with low-dose cyclophosphamide plus G-CSF. Callera F; Cavenaghi L; de Melo CM Transfus Apher Sci; 2009 Apr; 40(2):91-5. PubMed ID: 19233728 [TBL] [Abstract][Full Text] [Related]
29. Bortezomib administered pre-auto-SCT and as maintenance therapy post transplant for multiple myeloma: a single institution phase II study. Uy GL; Goyal SD; Fisher NM; Oza AY; Tomasson MH; Stockerl-Goldstein K; DiPersio JF; Vij R Bone Marrow Transplant; 2009 May; 43(10):793-800. PubMed ID: 19029964 [TBL] [Abstract][Full Text] [Related]
30. Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation. Copelan E; Hoshaw-Woodard S; Elder P; Penza S; Farag S; Marcucci G; Lin T; Ezzone S; Scholl MD; Bechtel T; Lemeshow S; Avalos B Bone Marrow Transplant; 2004 Jul; 34(1):85-7. PubMed ID: 15156164 [TBL] [Abstract][Full Text] [Related]
31. Brachial plexopathy following high-dose melphalan and autologous peripheral blood stem cell transplantation. Parrish C; Ming A; Patmore R; Shields M; Allsup D Bone Marrow Transplant; 2010 May; 45(5):951-2. PubMed ID: 19767786 [No Abstract] [Full Text] [Related]
32. Non-cryopreserved peripheral blood stem cells autologous transplantation in multiple myeloma: Bicentric study. Jennane S; Hasnaoui N; Mahtat EM; Merimi F; Bougar S; El Maaroufi H; Belmekki A; Zafad S; Essakalli M; Mikdame M; Doghmi K Transfus Clin Biol; 2020 Aug; 27(3):152-156. PubMed ID: 32334934 [TBL] [Abstract][Full Text] [Related]
33. Once weekly recombinant human erythropoietin therapy is very efficient after allogeneic peripheral blood stem cell transplantation when started soon after engraftment. Baron F; Frère P; Beguin Y Haematologica; 2003 Jun; 88(6):718-20. PubMed ID: 12801852 [No Abstract] [Full Text] [Related]
34. [Effect of autologous peripheral blood stem cell transplantation for multiple myeloma: a multi-institutional survey]. Inaba W; Shimazaki C Rinsho Ketsueki; 2002 May; 43(5):337-40. PubMed ID: 12096481 [No Abstract] [Full Text] [Related]
35. Reduced hemoglobin on day of peripheral blood progenitor cell collection is associated with low graft content of vascular progenitors and increased toxicity after autologous hematopoietic stem cell transplantation. Kasbia G; Al-Gahtani F; Tay J; Labonté L; Tinmouth A; Ramsay T; Gillingham A; Yang L; Halpenny M; Giulivi A; McDiarmid S; Huebsch L; Allan DS Transfusion; 2008 Nov; 48(11):2421-8. PubMed ID: 18673346 [TBL] [Abstract][Full Text] [Related]
36. High CD8+ lymphocyte dose in the autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation. Atta EH; de Azevedo AM; Maiolino A; Coelho CJ; Sarcinelli SM; de Alvarenga Máximo C; Marra VL Am J Hematol; 2009 Jan; 84(1):21-8. PubMed ID: 19006229 [TBL] [Abstract][Full Text] [Related]
37. Symptom burden in patients undergoing autologous stem-cell transplantation. Anderson KO; Giralt SA; Mendoza TR; Brown JO; Neumann JL; Mobley GM; Wang XS; Cleeland CS Bone Marrow Transplant; 2007 Jun; 39(12):759-66. PubMed ID: 17438588 [TBL] [Abstract][Full Text] [Related]
38. The role of stem cell mobilization regimen on lymphocyte collection yield in patients with multiple myeloma. Hiwase DK; Hiwase S; Bailey M; Bollard G; Schwarer AP Cytotherapy; 2008; 10(5):507-17. PubMed ID: 18608354 [TBL] [Abstract][Full Text] [Related]
39. Outcome after autologous stem cell transplantation for multiple myeloma in patients with preceding plasma cell disorders. Kumar SK; Dingli D; Lacy MQ; Dispenzieri A; Hayman SR; Buadi FK; Rajkumar SV; Litzow MR; Gertz MA Br J Haematol; 2008 Apr; 141(2):205-11. PubMed ID: 18318761 [TBL] [Abstract][Full Text] [Related]
40. Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis. Slovacek L; Slovackova B; Pavlik V; Hrstka Z; Macingova Z; Jebavy L; Horacek JM Neoplasma; 2008; 55(4):350-5. PubMed ID: 18505348 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]